优点:喘的临床缓解 - - 对喘管理的影响
Stefania Principe1, Nizar N Jarjour2
1Amsterdam UMC, Location Vrije University Medical Center, Department of Respiratory Medicine, Amsterdam, The Netherlands.
概括
喘生物药物为缓解提供了一条新的途径,其特点是控制症状和改善肺功能. 实现喘缓解需要一个共同的定义和积极的管理,以获得更好的长期患者结果.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 尽管取得了进展,但许多喘患者经历了持续的症状和恶化.
- 生物药物代表了严重喘管理的重大进步,准分子途径.
- 实现喘缓解是一种新的治疗可能性.
研究的目的:
- 审查支持喘缓解作为管理目标的研究.
- 突出生物制剂在实现缓解中的作用.
- 讨论缓解对喘护理的影响.
主要方法:
- 关于喘缓解和生物学的研究的综合文献综述.
- 对现实世界的数据和后期临床试验结果的分析.
- 检查当前的喘缓解的定义和指标.
主要成果:
- 生物药物显示出在很大一部分患者中实现临床缓解的潜力.
- 缓解的关键指标包括高喘控制,没有恶化和稳定的肺功能.
- 目前关于缓解的定义缺乏普遍共识.
结论:
- 喘缓解应该被视为一个潜在的管理目标.
- 专注于长期成果的积极管理至关重要.
- 需要进一步的前性研究来建立缓解的普遍定义.
相关概念视频
Asthma-III: Symptoms and Complications
2.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.4K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-IV: Nursing Management
2.9K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
2.9K
Asthma: Pathogenesis and Management
272
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
272
COPD: Management Using Bronchodilators and Corticosteroids
152
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
152
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K


